From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 954,165 shares, representing 2.5% for $75.46 million under the buyback announced on November 4, 2019.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
42.97 USD | -.--% | -.--% | +2.85% |
1st Jan change | Capi. | |
---|---|---|
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- TARO Stock
- News Taro Pharmaceutical Industries Ltd.
- Tranche Update on Taro Pharmaceutical Industries Ltd.'s Equity Buyback Plan announced on November 4, 2019.